76
Views
71
CrossRef citations to date
0
Altmetric
Article

Complementary Roles of Intracellular and Pericellular Collagen Degradation Pathways In Vivo

, , , , , , & show all
Pages 6309-6322 | Received 16 Feb 2007, Accepted 27 Jun 2007, Published online: 27 Mar 2023
 

Abstract

Collagen degradation is essential for cell migration, proliferation, and differentiation. Two key turnover pathways have been described for collagen: intracellular cathepsin-mediated degradation and pericellular collagenase-mediated degradation. However, the functional relationship between these two pathways is unclear and even controversial. Here we show that intracellular and pericellular collagen turnover pathways have complementary roles in vivo. Individual deficits in intracellular collagen degradation (urokinase plasminogen activator receptor-associated protein/Endo180 ablation) or pericellular collagen degradation (membrane type 1-matrix metalloproteinase ablation) were compatible with development and survival. Their combined deficits, however, synergized to cause postnatal death by severely impairing bone formation. Interestingly, this was mechanistically linked to the proliferative failure and poor survival of cartilage- and bone-forming cells within their collagen-rich microenvironment. These findings have important implications for the use of pharmacological inhibitors of collagenase activity to prevent connective tissue destruction in a variety of diseases.

SUPPLEMENTAL MATERIAL

We thank Mary Jo Danton for carefully reading the manuscript, Yanming Bi for help with computer tomography, and Ludmila Szobova for chondrocyte preparations.

This work was supported by the NIDCR Intramural Research Program and by a grant from the Department of Defense (DAMD-17-02-0693) to Thomas H. Bugge. Lars H. Engelholm and Niels Behrendt were supported by EU contract LSHC-CT-2003-503297 and by grants from the Danish Cancer Society, the Danish Cancer Research Foundation, and the Danish Medical Research Council.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.